Lindsey Marie Hartley sold $46k of AXGN
CFO at Axogen, Inc.. 1,051 shares at an average of $43.67, traded May 7, 2026, filed May 8, 2026.
Score components
- +22RoleCFO
- +6Trade size$46k at market
- 0Share of holdings soldSold 1.7% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000805928-26-000067, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 7, 2026 | MOption exercise Common Stock | +2,500 | $8.20 | $21k | 63,234 | May 8, 2026 |
| May 7, 2026 | SOpen-market sale Common Stock | -478 | $43.67 | $21k | 62,756 | May 8, 2026 |
| May 7, 2026 | MOption exercise Common Stock | +2,963 | $8.27 | $25k | 65,719 | May 8, 2026 |
| May 7, 2026 | SOpen-market sale Common Stock | -573 | $43.67 | $25k | 65,146 | May 8, 2026 |
| May 7, 2026 | MOption exercise Employee Stock Option (right to purchase)derivative | -2,500 | $0.00 | $0 | 0 | May 8, 2026 |
| May 7, 2026 | MOption exercise Employee Stock Option (right to purchase)derivative | -2,963 | $0.00 | $0 | 0 | May 8, 2026 |
Related signals
Other insiders at Axogen, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 11Weak | Axogen, Inc. | Joseph A. Tyndall director | $174k 3,500 shares | -25% | |
| 23Weak | Axogen, Inc. | Amy McBride Wendell director | $70k 1,647 shares | -2% | |
| 41Moderate | Axogen, Inc. | Doris Quackenbush Sales VP | $169k 3,878 shares | -4% | |
| 41Moderate | Axogen, Inc. | Jens Kemp Chief Marketing Officer | $174k 4,000 shares | -5% | |
| 56Moderate | Axogen, Inc. | Kathy Johnson Weiler director | $721k 16,344 shares | -100% | |
| 53Moderate | Axogen, Inc. | John Johnson director | $478k 11,050 shares | -100% | |
| 11Weak | AXGNsell Axogen, Inc. | Erick Wayne DeVinney Chief Innovation Officer | $171k 5,221 shares | -2% | |
| 49Moderate | Axogen, Inc. | Lindsey Marie Hartley CFO | $442k 14,812 shares | -32% | |
| 60Notable | Axogen, Inc. | Kathy Johnson Weiler director | $1.4M 46,653 shares | -100% | |
| 50Moderate | Axogen, Inc. | Amy McBride Wendell director | $1.3M 43,684 shares | -32% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.